Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Tilz, H; Becker, JC; Legat, F; Schettini, AP; Inzinger, M; Massone, C.
Allopurinol in the treatment of acquired reactive perforating collagenosis.
An Bras Dermatol. 2013; 88(1):94-97
Doi: 10.1590/s0365-05962013000100012
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Massone Cesare
- Co-Autor*innen der Med Uni Graz
- Becker Jürgen Christian
- Inzinger Martin
- Legat Franz
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Acquired reactive perforating collagenosis is a perforating dermatosis usually associated with different systemic diseases, mainly diabetes mellitus and/or chronic renal insufficiency. Different therapies have been tried but treatment is not standardized yet and remains a challenge. In the last few years, allopurinol has been reported as a good therapeutic option for acquired reactive perforating collagenosis. We describe the case of a 73-year-old man affected by acquired reactive perforating collagenosis associated with diabetes type 1 and chronic renal failure with secondary hyperparathyroidism. The patient was successfully treated with allopurinol 100mg once/day p.o..
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Allopurinol - therapeutic use
- Collagen Diseases - drug therapy
- Collagen Diseases - etiology
- Diabetes Mellitus, Type 1 - complications
- Free Radical Scavengers - therapeutic use
- Humans -
- Hyperparathyroidism, Secondary - complications
- Kidney Failure, Chronic - complications
- Male -
- Find related publications in this database (Keywords)
- Allopurinol
- Diabetes mellitus
- Prurigo
- Renal insufficiency
- Chronic
- Kidney failure, chronic